FIE Launching event on 09/08/2024

Việt Nam, with its dynamic economic growth and increasing demand for high-quality healthcare services, represents a key market for Organon. The new entity will enhance Organon's ability to serve the Vietnamese market, foster local partnerships and contribute to the country's healthcare development.

"We are excited to embark on this journey in Việt Nam, a country with immense potential and a growing demand for quality healthcare," said Vo Thi Thuy Ha, Country Lead at Organon Vietnam. "Our commitment is to bring innovative solutions that address the unique healthcare needs of Vietnamese women. By establishing Organon as a foreign investment entity here, we aim to make a meaningful impact on the health and well-being of women and their families across the nation."

Vo Thi Thuy Ha, Country Lead at Organon Vietnam speaks at the event

Vo Thi Thuy Ha, Country Lead at Organon Vietnam speaks at the eventOrganon plans to introduce a range of healthcare products and services tailored to the needs of Vietnamese women. The company is particularly focused on addressing issues such as declining birth rates and unintended pregnancies. Nearly half of all pregnancies in Vietnam are unintended, posing significant challenges to women's health and wellbeing. These unintended pregnancies often result in unsafe abortions, contributing to maternal mortality and other health complications.

"With more than two billion people in this region, we are committed to making a world of difference in women's health every day," said Andreas Daugaard Jorgensen, Managing Director of Organon Asia Pacific. "Việt Nam's dynamic market presents a tremendous opportunity for us to contribute to the healthcare sector and improve the lives of many."

Andreas Daugaard Jorgensen, Managing Director of Organon Asia Pacific

To tackle these issues, Organon has signed a Memorandum of Understanding with the Vietnam Population Authority. This partnership aims to improve access to contraception and reproductive health education through new digital resources and a hotline for women aged 19 to 24 years. By empowering women with knowledge and resources, Organon strives to reduce unintended pregnancies and promote safer reproductive health practices.

About Organon

Organon is a global healthcare company with a focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in innovation and future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialise their products by leveraging its scale and presence in fast growing international markets.